Skip to main content
. 2002 Nov;236(5):667–675. doi: 10.1097/00000658-200211000-00018

graphic file with name 18FF2.jpg

Figure 2. Effect of anti-IL-2R mAb on anti-CD154 mAb therapy in the C57BL/6 into BALB/c cardiac transplant model. The concomitant use of anti-IL-2R mAb abrogated the effect of single-dose anti-CD154 mAb on cardiac allograft survival (P = .0038 vs. sMR1 alone).